secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2024-05-13T23:59:59+00:00
Accession:  0001193125-24-137269
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health closes $4M public offering of common stock and warrants
--------------------------------------------------------------------

- Offering of 4.71M shares, Series A warrants for 4.71M shares, and Series B warrants for 7.065M shares at $0.85/unit.
- Gross proceeds ~$4.0M; net proceeds ~$3.5M after fees and expenses.
- Series A warrants exercisable at $0.85, expire 1 year; Series B warrants at $0.85, expire 5 years.
- Placement agent Maxim Group LLC received 7% cash fee ($280k) and 188,400 placement agent warrants at $0.935.
- Officers and directors subject to 90-day lock-up; company restricted from variable-rate transactions for 6 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000119312524137269/0001193125-24-137269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000119312524137269/d831053d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-137269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer